Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 8/20 | 0.46 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.44 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.44 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.44 |
| ▸ | HNF4A | P41235 | 1/20 | 0.43 |
| ▸ | ASIC3 | Q9UHC3 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30132918 | 0.84 | ALDH1A1 (0.47) | MAPTGRM5HNF4AASIC3ATM | |
| SCHEMBL29357652 | 0.84 | APP (0.67) | APPMAPTGRM5CA12CA1 | |
| SCHEMBL55761 | 0.84 | APP (0.67) | APPMAPTGRM5CA12CA1 | |
| SCHEMBL23482885 | 0.82 | APP (0.46) | APPMAPTGRM5ASIC3CA12 | |
| SCHEMBL442909 | 0.81 | APP (0.50) | APPMAPTGRM5ASIC3CA1 | |
| SCHEMBL552149 | 0.80 | APP (0.44) | APPMAPTGRM5CA12CA1 | |
| SCHEMBL29379887 | 0.80 | APP (0.44) | APPMAPTGRM5ASIC3ATM | |
| SCHEMBL30310282 | 0.80 | APP (0.44) | APPMAPTGRM5CA12CA1 | |
| SCHEMBL574585 | 0.80 | APP (0.44) | APPMAPTGRM5ASIC3ATM | |
| SCHEMBL5683034 | 0.80 | APP (0.55) | APPMAPTGRM5ASIC3CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240270666-A1 | SYMMETRIC TETRAALKYNYLATED ANTHRACENES AND THE PROCESS FOR PREPARING THE SAME FOR SENSING AND OPTOELECTRONIC APPLICATIONS | INDIAN INSTITUTE OF TECHNOLOGY, GUWAHATI (IN) | 2024-08-15 | — | — | US | disclosed |
| WO-2023012678-A1 | SYMMETRIC TETRAALKYNYLATED ANTHRACENES AND THE PROCESS FOR PREPARING THE SAME FOR SENSING AND OPTOELECTRONIC APPLICATIONS | INDIAN INSTITUTE OF TECHNOLOGY, GUWAHATI (IN) | 2023-02-09 | — | — | WO | disclosed |
| EP-4069663-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2022-10-12 | — | — | EP | disclosed |
| CN-114746382-A | Material for organic electroluminescent device | 默克专利有限公司 | 2022-07-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240270666-A1 | SYMMETRIC TETRAALKYNYLATED ANTHRACENES AND THE PROCESS FOR PREPARING THE SAME FOR SENSING AND OPTOELECTRONIC APPLICATIONS | HCN3, HCN1, HCN2 | APP 2279/4885MAPT 4163/4885GRM5 4057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.